Certificate of Analysis
| Product Name: | Gardiquimod diTFA |
| Catalog Number: | M27867 |
| CAS Number: | 1159840-61-5 |
Physical and Chemical Properties
| Formula: | C21H25F6N5O5 |
| Molecular Weight: | 541.44 |
| Form: | Solid |
| Solubility: | DMSO 50 mg/mL (ultrasonic); Water 25 mg/mL (ultrasonic) |
| Storage: | 4°C, dry, sealed |
| Chemical Structure: |  |
Analytical Data
| QC Standard: | ≥99.0% |
| H-NMR: | Consistent with structure |
Product Information
| Description: | Gardiquimod diTFA, an imidazoquinoline analog, is a TLR7/8 agonist. Gardiquimod diTFA could inhibit HIV-1 infection of macrophages and activated peripheral blood mononuclear cells (PBMCs). Gardiquimod diTFA specifically activates TLR7 when used at concentrations below 10 μM. |
| Stability and Solubility Advice: | Information concerning product stability, particularly in solution, has rarely been reported and in most cases we can only offer a general guide. We recommend that stock solutions, once prepared, are stored aliquoted in tightly sealed vials and used within 1 month. Avoid repeated freeze and thaw cycles. Storage conditions for some special products should refer to their storage details. |